2013
DOI: 10.3109/10837450.2013.829091
|View full text |Cite
|
Sign up to set email alerts
|

A new deferiprone controlled release system obtained by ultrasound-assisted compression

Abstract: Carbopol 974P and 971P have been selected as matrix forming polymers for the final formulation. The polymer percolation threshold has been exceeded with 15% w/w of polymer. Therefore, sustained release tablets have been developed with only 15% of excipient. This implies that matrix tablets containing 750 mg of API, intended for two administrations a day, can be obtained with a similar weight to those existing in the market containing 500 mg of API for three administrations a day.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

1
3
0

Year Published

2015
2015
2025
2025

Publication Types

Select...
7
1

Relationship

1
7

Authors

Journals

citations
Cited by 9 publications
(4 citation statements)
references
References 23 publications
1
3
0
Order By: Relevance
“…So, the boundaries between particles become indistinguishable causing the sintering of the system. Some researchers have also confirmed the sintering process obtained with USAC by SEM [5,6,7,30]. It can be highlighted that acicular drug particles tend to be distributed in parallel thus offering the lowest porosity previously measured, and how TPU works binding these particles (Figure 5A,B).…”
Section: Resultssupporting
confidence: 64%
See 1 more Smart Citation
“…So, the boundaries between particles become indistinguishable causing the sintering of the system. Some researchers have also confirmed the sintering process obtained with USAC by SEM [5,6,7,30]. It can be highlighted that acicular drug particles tend to be distributed in parallel thus offering the lowest porosity previously measured, and how TPU works binding these particles (Figure 5A,B).…”
Section: Resultssupporting
confidence: 64%
“…This technology has been successfully employed for different applications as the amorphization of active pharmaceutical ingredients, production of solid dispersions to enhance the bioavailability of poorly soluble drugs and formulation of sustained drug release forms [3,6,7,8,9,10]. In the case of prolonged release systems, USAC appears as a promising technique, decreasing the cost and the quantity of excipient needed for the control of the drug release [8], which usually constitutes an important drawback in the formulation of sustained-release systems.…”
Section: Introductionmentioning
confidence: 99%
“…Another approach to prolonging the action of orally applied chelating therapeutics is a sustained release oral formulation, as demonstrated on deferiprone [149].…”
Section: Polymers With Bound Chelators To Be Applied Orallymentioning
confidence: 99%
“…3,[15][16][17] The same was compared to the formulation containing HPMC in the same amount. Matrix rutin tablets (10 mg dose) were prepared by direct compression method.…”
Section: Matrix Tablet Preparationmentioning
confidence: 99%